関連する実験動画
Updated: Aug 12, 2026

11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
静脈内注射したストレプトキナーゼ後のアンチストレプトキナーゼの位数は,
1Department of Haematology, University Hospital, Queen's Medical Centre, Nottingham, UK.
Lancet (London, England)
|January 27, 1990
まとめ
心臓発作の治療のためにストレプトキナーゼを投与している患者は,高レベルの中和抗体を発症します. これらの抗体は,ストレプトキナーゼの治療用量を最大1年間中和させ,再治療の決定に影響を及ぼします.
科学分野:
- 心臓病学 心臓病学
- 免疫学 免疫学とは
背景:
- ストレプトキナーゼは,急性心筋梗塞で使用される血栓解消剤です.
- ストレプトキナーゼに対する中和性抗体は,治療後に発達することがあります.
- これらの抗体の再治療への影響は,臨床的懸念事項である.
研究 の 目的:
- 急性心筋梗塞の治療を受けた患者のストレプトキナーゼ中和タイトルの測定.
- 中和抗体反応の持続時間とレベルを評価する.
- ストレプトキナーゼの再投与に関する決定を導くために.
主な方法:
- 25人の患者でストレプトキナーゼ中和タイターの測定.
- トリートメント前,3ヶ月後,および治療後4.5〜8.5ヶ月間に行われた定位.
- 治療用量に関連した抗体レベルの分析.
主要な成果:
- 治療前のタイターは,すべての患者で低かった.
- 3ヶ月後,24人の患者は,治療用量の全量を中和するタイトルを有していた.
- 4.5-8.5ヶ月間で,20人の患者のうち18人が有意な中和能力を示した.
- 8ヶ月後のタイトルは,0.4~2百万ユニットでした.
結論:
- 患者は治療後,ストレプトキナーゼを中和する抗体を有意に発達させる.
- これらの抗体は少なくとも8ヶ月,潜在的に最大1年間持続します.
- 8〜12ヶ月以内にストレプトキナーゼによる再治療は,プラズマ中和能力と投与量の調整を考慮する必要があります.
関連する概念動画
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

